反応式
[CH3:1][C:2]1[N:3]=[CH:4][C:5]([NH:8][C:9]2[C:18]3[C:13](=[CH:14][CH:15]=[C:16]([OH:19])[CH:17]=3)[N:12]=[CH:11][N:10]=2)=[N:6][CH:7]=1.C(O[CH:23](OCC)[CH2:24][O:25][C:26]1[CH:27]=[CH:28][C:29](F)=[N:30][CH:31]=1)C.[CH:36]([NH2:39])([CH3:38])[CH3:37]>>[CH:36]([NH:39][CH2:23][CH2:24][O:25][C:26]1[CH:27]=[CH:28][C:29]([O:19][C:16]2[CH:17]=[C:18]3[C:13](=[CH:14][CH:15]=2)[N:12]=[CH:11][N:10]=[C:9]3[NH:8][C:5]2[CH:4]=[N:3][C:2]([CH3:1])=[CH:7][N:6]=2)=[N:30][CH:31]=1)([CH3:38])[CH3:37]参加物
4
実験手順
Using 4-[(5-methylpyrazin-2-yl)amino]quinazolin-6-ol, 5-(2,2-diethoxyethoxy)-2-fluoropyridine and isopropylamine, and in the same manner as in Example 31 or according to a method similar to it or according to a combination thereof with an ordinary method, the entitled compound (62 mg) was obtained as a pale yellow solid.
出典と根拠
- ORDレコード
- ord-34ecc08e5aa84568b9e3fab9a9c5c72a
- 出典データセット
- uspto-grants-2014_09
- 特許番号
- US08846700B2
関連ノート
読み込み中…